For the year ending 2025-12-31, MEDP has $1,975,472K in assets. $1,516,401K in debts. $497,049K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 497,049 | |||
| Accounts receivable and unbilled, net (includes 3.5 million and 4.2 million with related parties at december31, 2025 and 2024, respectively) | 402,078 | |||
| Prepaid expenses and other current assets | 90,497 | |||
| Total current assets | 989,624 | |||
| Property and equipment, net | 131,055 | |||
| Operating lease right-of-use assets | 117,815 | |||
| Goodwill | 662,396 | |||
| Intangible assets, net | 33,420 | |||
| Deferred income taxes | 19,223 | |||
| Other assets | 21,939 | |||
| Total assets | 1,975,472 | |||
| Accounts payable (includes 0.3 million and 0.2 million with related parties at december31, 2025 and 2024, respectively) | 28,142 | |||
| Accrued expenses | 408,382 | |||
| Advanced billings (includes 12.3 million and 14.6 million with related parties at december31, 2025 and 2024, respectively) | 854,390 | |||
| Other current liabilities | 52,834 | |||
| Total current liabilities | 1,343,748 | |||
| Operating lease liabilities | 113,643 | |||
| Deferred income tax liability | 1,355 | |||
| Other long-term liabilities | 57,655 | |||
| Total liabilities | 1,516,401 | |||
| Common stock - 0.01 par-value 250,000,000 shares authorized at december31, 2025 and 2024 28,370,780 and 30,630,799 shares issued and outstanding at december31, 2025 and 2024, respectively | 284 | |||
| Treasury stock - 69,623 and 70,073 shares at december31, 2025 and 2024, respectively | 12,156 | |||
| Additional paid-in capital | 935,830 | |||
| (accumulated deficit) retained earnings | -459,981 | |||
| Accumulated other comprehensive loss | -4,906 | |||
| Total shareholders equity | 459,071 | |||
| Total liabilities and shareholders equity | 1,975,472 | |||
Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. (MEDP)